Annual stakeholder survey

HPIO invites your feedback in improving our work and assessing our effectiveness. Please take our 11-question stakeholder survey.

AEP: Prevention, treatment and recovery

This resource page is part of the HPIO Addiction Evidence Project and covers topics relevant to three components of the comprehensive policy response to addiction framework: Prevention, treatment and recovery. Click here to view other phases of the Addiction Evidence Project.

Prevention

2020-2022 State Health Improvement Plan

Ohio Department of Health, 2020
Visit

Recommendations to prevent drug dependence/abuse and overdose deaths based on a review of research evidence and input from Ohio stakeholders.

Substance Misuse Prevention for Young Adults

U.S. Substance Abuse and Mental Health Services Administration, 2019
Visit

National report that supports health care providers, systems and communities seeking to prevent substance misuse among young adults. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges and offers useful resources.

National Institute on Alcohol Abuse and Alcoholism’s CollegeAIM, 2019

Planning Alcohol Interventions Using NIAAA’s CollegeAIM Alcohol Intervention Matrix
Visit

Report that contains evidence-based interventions to inform and guide college officials on creating strategies to reduce underage drinking and alcohol-related harm on campuses.

U.S. Preventive Services Task Force, 2018

Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions
Visit

Recommendations for clinicians, developed by an independent expert panel, on appropriate and effective use of screening and brief counseling to reduce alcohol misuse among adults and adolescents.

Trust for America’s Health, 2017

Pain in the Nation: The Drug, Alcohol and Suicide Crisis and the Need for a National Resilience Stra
Visit

Report that includes list of evidence-based and promising policies and programs prevent excessive drinking (see Section 4 and Appendix A).

American Academy of Pediatrics, 2010

Policy Statement: Alcohol Use by Youth and Adolescents: A Pediatric Concern
Visit

Recommendations related to screening and treating alcohol abuse in adolescents.

Centers for Disease Control and Prevention, U.S. Department of Health and Human Services

The Community Guide
Visit

Systematic reviews of community preventive services, including strategies to prevent excessive alcohol consumption and tobacco use.

National Academies of Sciences, Engineering and Medicine, 2017

The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations f
Visit

Summarizes the current state of evidence regarding what is known about the health impacts of cannabis and cannabis-derived products, including effects related to therapeutic uses of cannabis and potential health risks related to certain cancers, diseases, mental health disorders, and injuries.

See also: HPIO medical marijuana resource page

Prevention Solutions, Education Development Center, 2017

Preventing Youth Marijuana Use: Programs and Strategies
Visit

A tool to help identify evidence-based youth marijuana prevention programs to implement in one’s community.

American Academy of Pediatrics, 2015

Policy Statement: The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update
Visit

Recommendations related to marijuana legalization and use in the child and adolescent populations.

Group 6

American Heart Association (and several other organizations), 2019

Tobacco 21: Model Policy
Download

Sample policy created by a consortium of national public health organizations to guide state and local jurisdictions on the development of policies to increase the minimum legal sales age for tobacco products. Addresses licensing, definitions, enforcement and other topics.

American Cancer Society, 2018

The American Cancer Society public health statement on eliminating combustible tobacco use in the Un
Visit

Policy statement that sets forth strategies to keep future generations from initiating the use of tobacco.

National Academies of Sciences, Engineering and Medicine, 2018

Public Health Consequences of E-Cigarettes
Visit

Consensus study report that summarizes the current state of evidence regarding what is known about health effects, initiation and cessation of combustible tobacco cigarette use and harm reduction.

Health Policy Institute of Ohio, 2017

State Policy Options Fact Sheet: Reduce Tobacco Use and Secondhand Smoke Exposure
Visit

Fact sheet that identifies four policy options to reduce tobacco use and secondhand smoke exposure based upon availability of strong evidence of effectiveness and relevance to Ohio’s state policy landscape.

Group 6

Public Health Law Center, 2016

Tobacco 21: Tips and Tools
Download

Technical assistance developed by the Tobacco Control Legal Consortium to advise jurisdictions on the policy implications of changes to the minimum legal sales age for tobacco products.

Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services

Agency for Healthcare Research and Quality (AHRQ) Innovations Exchange
Visit

Searchable database that rates the strength of evidence of effectiveness (strong, moderate, suggestive) for a wide range of clinical health care innovations.

Centers for Disease Control and Prevention, U.S. Department of Health and Human Services

The Community Guide
Visit

Systematic reviews of community preventive services, including strategies to prevent excessive alcohol consumption and tobacco use.

Centers for Disease Control and Prevention, U.S. Department of Health and Human Services

Community Health Improvement Navigator Database of Interventions
Visit

Searchable compendium of interventions, focused primarily on chronic disease prevention, including tobacco prevention and cessation. (Does not specifically address addiction to other drugs.)

Treatment

Health Affairs, 2020

Contingency Management: A Highly Effective Treatment For Substance Use Disorders And The Legal Barri
Visit

An overview of the evidence of effectiveness for contingency management to improve outcomes for people with a substance use disorder.

Ohio Department of Health, 2020

2020-2022 State Health Improvement Plan
Visit

Recommendations to reduce drug dependence/abuse and overdose deaths, including strategies to improve behavioral health access, system quality and workforce, based on a review of research evidence and input from Ohio stakeholders.

University of Pennsylvania Leonard Davis Institute of Health Economics, 2022

Lowering the Barriers to Medication Treatment for People with Opioid Use Disorder: Evidence for a Lo
Visit

An issue brief discussing the barriers to treatment for opioid use disorder, the evidence supporting a “low-threshold” approach for MAT and areas for future research.

Group 6

Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Hu

Buprenorphine Quick Start Pocket Guide
Download

Concise guide for physicians on best practices for use of Buprenorphine for the treatment of opioid use disorder.

American Society of Addiction Medicine (ASAM), 2020

National Practice Guideline for the Treatment of Opioid Use Disorder
Visit

Updated guidance for clinicians, developed by an independent committee of experts, on the appropriate and effective use of medications (methadone, buprenorphine/Suboxone, naltrexone/Vivitrol) and psychosocial methods to evaluate and treat opioid use disorder and opioid overdose.

National Academies of Sciences, Engineering and Medicine (NASEM), 2019

Medications for Opioid Use Disorder Save Lives
Visit

Expert consensus statement on the effectiveness of medication-based treatment for opioid use disorder, included best treatment practices in different care settings and best practices for treating different populations, such as pregnant women, racial and ethnic minority populations, and individuals with comorbidities.

Drug and Alcohol Dependence, 2018

The national implementation of Contingency Management (CM) in the Department of Veterans Affairs: At
Visit

An academic article reporting attendance and substance use outcomes for contingency management programs at the Department of Veterans Affairs compared to outcomes in controlled clinical trials.

American Academy of Pediatrics (AAP), 2017

A Public Health Response to Opioid Use in Pregnancy
Visit

Recommendations for a public health response to opiate use and abuse in pregnancy.

American Society of Addiction Medicine (ASAM), 2017

ASAM Consensus Document on Drug Testing in Clinical Addiction Medicine
Visit

Guidance for clinicians about the effective use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with, or at risk for, addiction.

American Society of Addiction Medicine and the American Congress of Obstetrician and Gynecologists,

Opioid Use and Opioid Use Disorder in Pregnancy
Visit

This committee opinion is a resource for clinicians in obstetrics and gynecology related to opioid screening and prescribing.

BMJ, 2017

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis o
Visit

Systematic review reporting on the effectiveness of opioid substitution treatment (methadone and buprenorphine) at reducing the risk of all cause and overdose mortality.

American Academy of Pediatrics (AAP), 2016

Medication-Assisted Treatment of Adolescents with Opioid Use Disorders
Visit

Recommendations for MAT of adolescents with opioid use disorders.

Group 6

Center for Medicaid and CHIP Services, Centers for Medicare and Medicaid Services (CMS), U.S. Depart

Best Practices for Addressing Prescription Opioid Overdoses, Misuse and Addiction (information bulle
Download

Describes Medicaid pharmacy benefit management strategies for mitigating prescription drug abuse, such as provider education, preferred drug lists, clinical criteria, prior authorization, quantity limits and increased use of Prescription Drug Monitoring Programs (PDMPs). Also addresses strategies state Medicaid programs can take to increase provision of naloxone for overdose reversal and access to opioid use disorder treatment.

Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Hu

Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder: A Br
Visit

Guidance for clinicians, developed by a consensus panel, on the appropriate and effective use of injectable naltrexone (Vivitrol).

Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Hu

Federal Guidelines for Opioid Treatment Programs
Visit

Description of minimum acceptable standards for opioid treatment programs (OTPs)—treatment providers that administer methadone and/or buprenorphine (Suboxone)—developed by a panel of experts.

American Society of Addiction Medicine (ASAM), 2013

ASAM Criteria (actual text is not available for free; must order)
Visit

Comprehensive set of guidelines for placement, continued stay and transfer/discharge of patients with addiction and co-occurring conditions. Designed for addiction treatment providers serving adolescents and adults.

Group 6

Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Hu

Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs (OTP): A Treatment I
Download

Detailed best-practice guidelines, developed by a consensus panel, to inform Opioid Treatment Programs (OTPs)—treatment providers that administer methadone, buprenorphine (Suboxone), LAAM or naltrexone (Vivitrol).

Group 6

Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Hu

Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction: A Treatment I
Download

Detailed best-practice guidelines, developed by a consensus panel, to inform use of buprenorphine in opioid addiction treatment.

Group 6

American Society for Addiction Medicine (ASAM), 2020

The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management
Download

Clinical practice guideline on alcohol withdrawal management.

American Psychiatric Association, 2018

Practice Guideline for the Pharmacological Treatment of Patients with Alcohol Use Disorder
Visit

Guidance for clinicians based on a review of the research evidence. Includes specific recommendations on Medication-Assisted Treatment (MAT) and nonpharmacological therapies for patients who are seeking to reduce their alcohol consumption or achieve abstinence.

Alcohol Research and Health, 2011

The Community Reinforcement Approach: An Update of the Evidence
Visit

Report providing evidence for two off-shoots of the community reinforcement approach for adolescents and treatment-refusing individuals and their families.

American Academy of Pediatrics, 2010

Policy Statement: Alcohol Use by Youth and Adolescents: A Pediatric Concern
Visit

Recommendations related to screening and treating alcohol abuse in adolescents.

Group 6

American Academy of Family Physicians

Addressing Alcohol Use practice manual: An Alcohol Screening and Brief Intervention Program
Download

A practice manual for clinicians to implement alcohol screening and brief intervention into their practices.

Substance Abuse and Mental Health Services Administration (SAMHSA), 2020

Evidence-Based Resource Guide Series: Treatment of Stimulant Disorders
Visit

SAMHSA guide on evidence-based treatment for stimulant use disorders, including guidance on selecting and implementing evidence-based treatment practices.

PLOS Medicine, 2018

Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine an
Visit

Systematic review reporting on the efficacy of psychosocial interventions to treat cocaine and/or amphetamine use to inform patients, clinicians and policymakers decision-making on interventions.

Group 6

National Institute on Drug Abuse, updated 2016

Cocaine
Download

Research report which includes summary of effective approaches to cocaine addiction treatment.

Group 6

National Institute on Drug Abuse, updated 2013

Methamphetamine
Download

Research report which includes summary of effective approaches to methamphetamine addiction treatment.

Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Hu

Treatment of Stimulant Use Disorders (Treatment Improvement Protocol No. 33)
Visit

Guidance for substance use disorder treatment providers on appropriate treatment of stimulant abuse and dependence, including addiction to cocaine and methamphetamine.

U.S. Preventive Services Task Force, 2020

Tobacco Use in Children and Adolescents: Primary Care Interventions
Visit

Recommendations for primary care clinicians, developed by an independent expert panel, on appropriate and effective use of education and brief counseling for tobacco cessation (nicotine addiction treatment) for children and adolescents.

Group 6

American College of Cardiology, 2018

2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment
Download

Expert consensus statement that provides a comprehensive approach for healthcare providers to evaluate and treat tobacco dependence.

National Academies of Sciences, Engineering and Medicine, 2018

Public Health Consequences of E-Cigarettes
Visit

Consensus study report that summarizes the current state of evidence regarding what is known about health effects, initiation and cessation of combustible tobacco cigarette use and harm reduction.

Health Policy Institute of Ohio, 2017

State Policy Options Fact Sheet: Reduce tobacco use and secondhand smoke exposure
Visit

Fact sheet that identifies four policy options to reduce tobacco use and secondhand smoke exposure based upon availability of strong evidence of effectiveness and relevance to Ohio’s state policy landscape.

U.S. Preventive Services Task Force, 2015

Tobacco Smoking Cessation in Adults, Including Pregnant Women: Behavioral and Pharmacotherapy Interv
Visit

Recommendations for clinicians, developed by an independent expert panel, on appropriate and effective use of screening, behavioral counseling and FDA-approved medications for tobacco cessation for adults.

Group 6

American Society of Health-System Pharmacists, 2009

ASHP Therapeutic Position Statement on the Cessation of Tobacco Use
Download

Explains epidemiology of tobacco use and health consequences. Presents strategies for promoting tobacco cessation and explains the health benefits of tobacco cessation.

Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services

Agency for Healthcare Research and Quality (AHRQ) Innovations Exchange
Visit

Searchable database that rates the strength of evidence of effectiveness (strong, moderate, suggestive) for a wide range of clinical health care innovations.

Centers for Disease Control and Prevention, U.S. Department of Health and Human Services

Community Health Improvement Navigator Database of Interventions
Visit

Searchable compendium of interventions, focused primarily on chronic disease prevention, including tobacco prevention and cessation. (Does not specifically address addiction to other drugs.)

Centers for Disease Control and Prevention, U.S. Department of Health and Human Services

The 6/18 Initiative
Visit

Evidence summaries for clinical prevention and treatment interventions to address high-burden health conditions, including tobacco use. (Does not specifically address addiction to other drugs.)

Recovery

National Alliance for Recovery (NARR) Residences, 2017 (revised from 2015)

NARR Standard Version 2.0 (Domains, core principles and standards)
Visit

A checklist of specific measures to be used by recovery residences (recovery housing) related to the administration of the residence and creating a supportive environment for recovery.

National Alliance for Recovery (NARR) Residences, 2016

NARR Code of Ethics
Visit

Code of ethics for recovery residence (recovery housing) owners, operators, staff and volunteers.

Group 6

National Alliance for Recovery (NARR) Residences, 2017 (revised from 2015)

NARR Standard Version 2.0 (Domains, core principles and standards)
Download

A checklist of specific measures to be used by recovery residences (recovery housing) related to the administration of the residence and creating a supportive environment for recovery.

Group 6

National Alliance for Recovery (NARR) Residences, 2016

NARR Code of Ethics
Download

Code of ethics for recovery residence (recovery housing) owners, operators, staff and volunteers.

Office of the Surgeon General, U.S. Department of Health and Human Services, 2016

Facing Addiction in America Chapter 5: Recovery: The Many Paths to Wellness
Visit

Summarizes research findings on the effectiveness of approaches used by mutual aid groups (such as 12-step groups) and recovery support services (such as peer recovery coaching, recovery housing).

Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Hu

What are Peer Recovery Support Services?
Visit

Description of models of peer recovery support services.

Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Hu

What are Peer Recovery Support Services?
Visit

Description of models of peer recovery support services.

Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Hu

What are Peer Recovery Support Services?
Visit

Description of models of peer recovery support services.

Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Hu

Integrating Substance Abuse Treatment and Vocational Services (Treatment Improvement Protocol Series
Visit

Best practice guidelines regarding vocational services to increase employment among substance abuse treatment clients.

Cochrane Collaboration

Cochrane Database of Systematic Reviews
Visit

Searchable database of systematic reviews on wide range of healthcare topics, including a “Tobacco, drugs and alcohol” category.

Sources

This resource page provides links to three types of credible guidance on what works to address addiction:

  • Expert consensus statements and guidelines: Recommendations developed by groups of experts convened by a federal agency, medical professional association or other credible organization. In most cases, these expert panels used a rigorous and systematic process to compile and evaluate peer-reviewed research evidence and translate research findings into specific implications for community-based prevention, clinical care or recovery services.
  • Evidence registries: Searchable databases or other user-friendly compilations of evidence-based policies and programs. These registries use specific screening criteria to identify effective strategies and/or rate strategies on the strength of their available evidence of effectiveness.
  • Model policies: Model legislation developed by experts.

HPIO annual stakeholder survey

HPIO invites your feedback in improving our work and assessing our effectiveness. Please take a few minutes to fill out this 11-question stakeholder survey.

Take stakeholder survey